Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F9CMY
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,067
Award facts
- Contract value 100% obligated
- $18,067.18 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 5, 2026, for the supply of Dupixent 300 mg/2 ml pens with a ceiling value of $18,067.18. This is a firm fixed price contract with no set-aside designation, competitively awarded through an open process. The delivery order is set to be completed by January 6, 2026, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Dupixent is a biologic medication used to treat atopic dermatitis, asthma, and other allergic conditions, representing a critical specialty pharmaceutical supply for military and federal healthcare systems.
This delivery order is a child contract issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a prime contract value of $999,999,999.00 through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medications and medical supplies to support military healthcare programs worldwide, including customers such as the Defense Health Agency and U.S. Coast Guard. As a major pharmaceutical distributor headquartered in Pennsylvania, AmerisourceBergen has established itself as a critical federal vendor through its consistent delivery of specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26F9CMY?
SPE2DR26F9CMY was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 5, 2026.
How much is contract SPE2DR26F9CMY worth?
The government has obligated $18,067 on SPE2DR26F9CMY.
Is contract SPE2DR26F9CMY an order under another contract?
Yes. SPE2DR26F9CMY is a delivery order under SPE2DR25D1017, an indefinite delivery contract.
Was contract SPE2DR26F9CMY competed?
The extent of competition for SPE2DR26F9CMY was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award